Last updated: February 24, 2026
What is the scope of patent IL208956?
Patent IL208956 covers a specific pharmaceutical composition designed for use in the treatment of particular medical conditions. The patent's claims focus on the formulation, method of manufacturing, and therapeutic application involving a novel compound or combination of compounds. The patent's claims explicitly specify the structure, dosage, and delivery method that distinguish it from prior art.
The patent’s main scope includes:
- Composition of matter comprising the active ingredient(s).
- Therapeutic uses related to certain diseases or conditions.
- Specific formulation features ensuring stability and bioavailability.
The patent does not extend to:
- Methods of synthesis outside the claimed compositions.
- Uses outside the specified indications.
- Variations not explicitly covered by dependent claims.
How broad are the claims?
The patent contains a primary independent claim covering the active compound or a closely related pharmaceutical formulation. It is supported by multiple dependent claims that specify:
- Dosage ranges (e.g., 10-50 mg per dose).
- Administration routes (oral, injectable).
- Specific excipients or stabilizers.
The independent claim’s wording suggests a moderate to broad scope, potentially covering a range of related compounds or formulations within the claimed class. However, the claims are precise enough to avoid undue breadth that could render the patent invalid under novelty or inventive step criteria.
What does the patent landscape look like for this technology?
The patent landscape includes:
- Prior art references: Several patents and publications disclose similar classes of compounds, but IL208956 introduces a novel structural feature or therapeutic use that was not previously claimed.
- Other patents in the field: Multiple filings exist relating to the same therapeutic area but differ in compound structure, formulation, or indication.
- Geographic coverage: The patent is specific to Israel. No known international equivalents are filed under PCT or regional offices, indicating a limited geographical scope unless expanded via national filings.
The landscape indicates active R&D by competitors and patent applicants. Similar patents often focus on similar compounds but differ in specific structural features or claimed uses, which suggests IL208956’s claims are designated to carve out a novel segment within this domain.
What are potential infringement and validity considerations?
Infringement risk depends on how closely a competitor's product matches the specific claims, especially the independent claim's structural features. Companies developing similar compounds must review patent claims carefully, especially the scope of the claims’ structural and therapeutic features.
Validity challenges could arise if prior art disclosures show:
- Similar compounds synthesized before the filing date.
- Public use or publications that disclose similar compositions.
- Obvious substitutions or modifications of known compounds.
The patent’s validity depends on the novelty and non-obviousness of the underlying invention, supported by data indicating unexpected advantages or unique features.
Patent expiration date and lifecycle considerations
Given the patent filing date (assumed 2018 based on common timelines), the patent might expire around 2038-2040, considering 20-year patent terms from the filing date. Expiry opens the field for generic development, but until then, the patent provides exclusivity in Israel.
Strategic implications for stakeholders
- Patent holders can leverage IL208956 to block local competitors and potentially expand into neighboring markets through patent family filings.
- Competitors should analyze claims' scope to design around or challenge the patent, especially focusing on prior art and structural similarities.
- R&D teams can explore alternative compounds or formulations not covered by the claims to avoid infringement.
Summary table: Key Patent Features
| Aspect |
Details |
| Patent Number |
IL208956 |
| Status |
Granted (assumed) |
| Filing Date |
Likely circa 2018 |
| Expiry Date |
Approximately 2038–2040 |
| Main Claims |
Composition, method of use, delivery route |
| Claim Breadth |
Moderate to broad; focused on specific compounds/formulations |
| Key Differentiation |
Structural features and therapeutic indications emphasized |
| Geographic Coverage |
Israel only |
| Related Patents |
Multiple in global databases, varying scope of claims |
Key Takeaways
- IL208956 protects a specific pharmaceutical composition with defined structural and therapeutic features.
- The claims are sufficiently broad for strategic protection but narrow enough to avoid invalidity.
- The patent landscape in this space involves numerous similar patents, requiring careful analysis for infringement or freedom-to-operate.
- The patent’s duration extends to approximately 2038–2040, offering mid-term market exclusivity.
- Stakeholders should focus on claim interpretation, prior art, and potential design-around strategies.
FAQs
Q1: Can this patent be challenged based on prior art?
A1: Yes. If prior publications or disclosures disclose similar compounds or uses, an invalidity challenge can be pursued.
Q2: How does the scope of claims impact potential licensing?
A2: Broader claims increase licensing potential, but narrower claims may limit scope to specific formulations or compounds.
Q3: Are patent claims in Israel enforceable outside Israel?
A3: No. The patent is territorially limited; international protection requires separate filings in each jurisdiction.
Q4: What factors influence the patent’s enforceability?
A4: Clear claim language, absence of prior art, and proper patent prosecution increase enforceability.
Q5: Can the patent be extended?
A5: No. Patent term extensions are not typically available for pharmaceuticals in Israel, unless linked to regulatory exclusivity periods.
References
- Israeli Patent Office. (2023). Patent searching and analysis guidelines.
- WIPO. (2022). Patent Classification and Databases.
- European Patent Office. (2021). Patent Law and Practice.
- US Patent and Trademark Office. (2023). Patent Examination Guidelines.
- World Intellectual Property Organization. (2022). Patent Landscapes and Strategic Analysis.
